InQpharm appoints the Asia/Pacific Regional Office in Kuala Lumpur, Malaysia, as its Global Operational Headquarters.

The Company makes another important step in its own growth and in supporting the Malaysian initiative to advance the local biotechnology industry with its research, development and commercialization expertise in unique natural compounds.

InQpharm announces that with immediate effect its Asia/Pacific regional office in Kuala Lumpur, Malaysia, will assume the role of Global Operational Headquarters. Having completed construction of its new, state of the art offices in Kuala Lumpur’s prestigious Mont Kiara district, the company announces a major expansion plan, which will see it double its work force in Malaysia by Year End 2007, tripling it by H2/2008. Originally established in 2005 to further InQpharm’s business activities in the region, as well as to establish new research initiatives using local plants and knowledge, the Operational HQ will now also assume global responsibility for the following disciplines:

-	Business Development
-	Marketing
-	Creative Design
-	Product Development
-	Finance
-	Legal
-	Intellectual Property
-	Total Quality Management
-	Regulatory Affairs
-	Human Resources

 

Commenting on the announcement today, Thomas Hafner, CEO of InQpharm, said: “Malaysia is not only blessed with a wealth of resources and a Government that is supportive of its biotechnology industry, but also with an extremely hard working, loyal, creative, well educated and positive workforce that not only represents extremely good value to the company, but is also simply a joy to work with. We have achieved a great deal in Malaysia during the past two years, giving us the confidence to make the next logical step, by making further significant investments in the country in terms of infrastructure and manpower. Having distribution on over 35 countries to date, we are committed to achieving significant global market penetration and by building our team in Malaysia, we are confident that we will achieve our goals sooner than originally envisaged. The next step hereafter will be to transfer some of InQpharm’s Clinical Research activities to Malaysia from its current R&D base in Berlin/Germany, which will commence during Q4/2007.”

The Asia/Pacific staff will continue to work closely with their colleagues at InQpharm’s European office in Berlin, Germany.

About Malaysia

Malaysia has the potential to be a biotechnology hub of significant presence. It aims to be the preferred destination for foreign and local companies to invest in. Malaysia will act as a magnet to attract the global scientific community to conduct research. It will provide a conducive environment that attracts the best minds, fuels dynamic, innovative research and investigation which will one day lead to breakthrough discoveries. Malaysia’s biotechnology thrust will be the catalyst that drives development and growth in biotechnology, bridging society with science, changing lives touched by it.

Integral to Malaysia’s objectives to emerge as a significant player in biotechnology, Malaysian Biotechnology Corporation (Biotechcorp) was set-up as the implementing agency responsible for furthering Malaysia’s biotechnology objectives. Biotechcorp, through its One-Stop-Center (OSC) provides a range of services supported by transparent processes that will ease the entry and setting-up of companies locally as well as promote the start-up, development and growth of local companies.

As one of the genuine pioneers of Malaysia’s Biotechnology Drive, InQpharm works very closely with Biotechcorp on achieving Malaysia’s and InQpharm’s objectives in a smart partnership.